| Study shows that quantitative CT analysis of orbital structures offers a potential, objective method for assessing TED activity, enabling clinicians to identify high-risk patients who may require prompt therapeutic intervention. Photo: Bobby Saenz, OD. Click image to enlarge. | In a recent study, researchers aimed to identify a relationship between orbital CT parameters (volume and density) and inflammatory activity in patients with thyroid eye disease (TED). The team found five predictors of active TED, including larger extraocular muscle (EOM) volume and higher intraorbital fat density, suggesting that quantitative CT analysis may be useful for assessing TED activity. The findings were reported in PLoS One. This retrospective study analyzed CT images and clinical records of 85 TED patients and 15 controls. Orbital segmentation was performed using commercially available software. The volumes and densities of the EOMs, intraorbital fat and lacrimal gland were measured. CT parameters were compared among the control, active TED and inactive TED groups. Patients were further classified into two subgroups based on disease severity: mild TED and moderate-to-severe TED. Patients with active TED (defined by a clinical activity score ≥3) demonstrated significantly larger EOM volumes and higher intraorbital fat densities compared to those with inactive TED. Five robust, independent predictors of active TED were found: - shorter disease duration - higher serum thyroid-stimulating immunoglobulin levels - larger EOM volume - higher EOM density - higher intraorbital fat density Combining clinical, serological and quantitative CT metrics resulted in exceptional diagnostic performance, indicated by an area under the ROC curve (AUC) of 0.938. Stratified analysis confirmed that EOM volume and intraorbital fat density remained significantly different between active and inactive TED groups across both mild and moderate-to-severe disease categories. In the moderate-to-severe subgroup, all four extraocular rectus muscles were larger in active TED patients. In the mild subgroup, only